Status:
RECRUITING
The Effects of Light Therapy to Treat Cancer-related Side Effects
Lead Sponsor:
Reykjavik University
Collaborating Sponsors:
The Icelandic Research Fund
Conditions:
Breast Cancer
Circadian Rhythms
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Severe fatigue, depression, sleep problems and cognitive impairment are the most commonly reported side effects of cancer treatment. These aversive side effects are hypothesized to be related to the d...
Eligibility Criteria
Inclusion
- Breast cancer Patients: Newly diagnosed patients with stages 1 to 3 breast cancer scheduled to undergo surgery (without chemotherapy) and newly diagnosed patients with stages 1 to 3 breast cancer scheduled to undergo both surgery and chemotherapy.
- Healthy controls: never received a cancer diagnosis
Exclusion
- Stage 3B breast cancer, inflammatory or stage 4 breast cancer; under age 18; pregnancy; pre-existing anemia (Hb \<10gm/dl); history of bipolar disorder or mania (which are contra-indications for BWL treatment); and any other physical or psychological impairments (e.g., sleep disorder diagnosis) which could limit participation.
Key Trial Info
Start Date :
June 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04418856
Start Date
June 8 2020
End Date
October 1 2024
Last Update
April 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reykjavik University
Reykjavik, Iceland, 102